드러그인포 약품 상세정보

허가정보

항목

내용

청구코드(KD코드)
비급여점검코드
상한금액

650203250[A08502261] [보험코드에 따른 약품기본정보 직접조회]

\0 원/1ml(2002.09.01)(최신약가)
[상병코드조회]
[질병코드집 다운로드] [우리집건강주치의 바로가기]

빠른조회


요약정보	[효능] [용법] [금기] [신중투여] [이상반응]

상세정보	[효능] [용법] [경고] [금기] [신중투여] [이상반응] [일반주의] [상호작용] [임산부] [수유부] [소아] [고령자] [신장애환자] [간장애환자] [적용주의] [과량투여] [임상검사치] [보관] [기타]

제품성상

백색 내지 미황색의 현탁성 액제 [제형정보 확인]

포장·유통단위

15ml, 1's.

주성분코드

A80300COS [동일한 주성분코드를 가진 오리지날 또는 제네릭 의약품 조회]

대표코드

8806502032509

약리작용

[조회]

효능효과

[적응증 별 검색]

비화농성 안검염, 안검결막염(알러지성 및 세균성), 비화농성 결막염(알러지성 및 세균성)

용법용량

* 절대 임의복용하지 마시고 반드시 의사 또는 약사와 상담하시기 바랍니다.

[처방약어]
[주성분코드:333800COS 에 따른 심사지침열람]
환자의 증상에 따라 1일 2-4회 1적씩 투여합니다.
[제형별복약지도]

[BMI지수 계산] [Body Surface Area 계산] [Cockcroft-Gault GFR 계산] [MDRD GFR 계산]

[피해야 할 음식] [복용을 잊은 경우 대처법]

주요약물 상호작용

[보기]

금기

헤르페스 심플렉스 각막염, 치료되지 않은 화농성 감염, 백시니아, 각막 및 결막의 바리셀라 바이러스 질환, 진균에 의한 안질환, 안결핵 환자

일반적 주의

미생물에 의한 감염시, 스테로이드에 의하여 염증이 강화 또는 활성화될 수 있다.
과량 사용은 민감한 사람에 있어서는 안압이 상승할 수 있다.
설폰아마이드에 민감한 환자에 사용시 주의하여야 한다. 4)각막이 얇아지는 질환에 있어서는 국소적으로 스테로이드의 사용에 의하여 천공이 올 수 있으므로 주의하여야 한다. 5)협각녹내장(narrow angle glaucoma)이 있는 경우에는 주의하여 사용하여야 한다. 6)국소적으로 부신피질호르몬 안약을 과량 사용한 후에는 수정체성 유맥증이 나타날 수 있다. 7)페닐에프린은 안과영역에 사용시 치료를 지연시키고 충혈 및 밀폐된 녹내장각의 침전을 유발한다는 보고가 있다.

Related FDA Approved Drug

기준 성분:SULFACETAMIDE SODIUM
BLEPH-10 (SULFACETAMIDE SODIUM)
BLEPH-30 (SULFACETAMIDE SODIUM)
BLEPHAMIDE (PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM)
BLEPHAMIDE S.O.P. (PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM)
CETAMIDE (SULFACETAMIDE SODIUM)
CETAPRED (PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM)
FML-S (FLUOROMETHOLONE; SULFACETAMIDE SODIUM)
ISOPTO CETAMIDE (SULFACETAMIDE SODIUM)
ISOPTO CETAPRED (PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM)
KLARON (SULFACETAMIDE SODIUM)
METIMYD (PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM)
OCUSULF-10 (SULFACETAMIDE SODIUM)
OCUSULF-30 (SULFACETAMIDE SODIUM)
PREDAMIDE (PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM)
PREDSULFAIR (PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM)
PREDSULFAIR II (PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM)
SODIUM SULAMYD (SULFACETAMIDE SODIUM)
SODIUM SULFACETAMIDE (SULFACETAMIDE SODIUM)
SULF-10 (SULFACETAMIDE SODIUM)
SULF-15 (SULFACETAMIDE SODIUM)
SULFACEL-15 (SULFACETAMIDE SODIUM)
SULFACETAMIDE SODIUM (SULFACETAMIDE SODIUM)
SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE (PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM)
SULFAIR 10 (SULFACETAMIDE SODIUM)
SULFAIR FORTE (SULFACETAMIDE SODIUM)
SULFAIR-15 (SULFACETAMIDE SODIUM)
SULPHRIN (PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM)
SULSTER (PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM)
SULTEN-10 (SULFACETAMIDE SODIUM)
VASOCIDIN (PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM)
기준 성분:PREDNISOLONE ACETATE
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE)
ECONOPRED (PREDNISOLONE ACETATE)
FLO-PRED (PREDNISOLONE ACETATE)
MEDROL (METHYLPREDNISOLONE ACETATE)
MEDROL ACETATE (METHYLPREDNISOLONE ACETATE)
METHYLPREDNISOLONE ACETATE (METHYLPREDNISOLONE ACETATE)
METICORTELONE (PREDNISOLONE ACETATE)
M-PREDROL (METHYLPREDNISOLONE ACETATE)
NEO-DELTA-CORTEF (NEOMYCIN SULFATE; PREDNISOLONE ACETATE)
NEO-MEDROL ACETATE (METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE)
OMNIPRED (PREDNISOLONE ACETATE)
POLY-PRED (NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE)
PRED FORTE (PREDNISOLONE ACETATE)
PRED MILD (PREDNISOLONE ACETATE)
PRED-G (GENTAMICIN SULFATE; PREDNISOLONE ACETATE)
PREDNISOLONE ACETATE (PREDNISOLONE ACETATE)
STERANE (PREDNISOLONE ACETATE)
기준 성분:PHENYLEPHRINE HYDROCHLORIDE
CYCLOMYDRIL (CYCLOPENTOLATE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE)
PHENERGAN VC (PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE)
PHENERGAN VC W/ CODEINE (CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE)
PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE (PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE)
PHERAZINE VC (PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE)
PHERAZINE VC W/ CODEINE (CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE)
PREFRIN-A (PHENYLEPHRINE HYDROCHLORIDE; PYRILAMINE MALEATE)
PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE (CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE)
PROMETH VC PLAIN (PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE)
PROMETH VC W/ CODEINE (CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE)
PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE)
PROMETHAZINE VC PLAIN (PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE)
PROMETHAZINE VC W/ CODEINE (CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE)

정보요약

드럭인포 의약품 요약/상세정보

코드 및 분류정보

항목	내용
주성분코드	A80300COS [동일한 주성분코드를 가진 오리지날 또는 제네릭 의약품 조회]
대표코드	8806502032509
BIT 약효분류	스테로이드를 포함한 안과용 항생제(Eye antiseptics with steroides)
ATC 코드	Prednisolone / S01CB02 [코드분류상세설명] [ATC코드예측]
복지부분류코드	131 (안과용제 )
의약품 바코드정보	내용보기 -:8806502018107 1개:8806502018114
주성분코드 분석 및 중복처방 검토	[주성분코드 분석 및 중복처방 검토]
Drugs By Indication	[전체보기]
Drugs By Classification	[전체보기]

제품정보

항목	내용
청구코드(KD코드) 비급여점검코드 상한금액	650203250[A08502261] [보험코드에 따른 약품기본정보 직접조회] \0 원/1ml(2002.09.01)(최신약가) [상병코드조회] [질병코드집 다운로드]
제품성상	백색 내지 미황색의 현탁성 액제 [제형정보 확인]
포장·유통단위	15ml, 1's.
동일주성분코드 검색순위	유료정보입니다.

복약정보

항목

내용

LACTmed 바로가기

[바로가기]

약리작용

유료정보입니다.

복약지도

유료정보입니다.

임부에대한투여

*	전체임신 기간별로 여러등급이 존재할 수 있으며 가장 위험도가 높은 정보만 보여집니다. 단, 복합제의 경우 모든 복합제성분에 대한 임부투여등급이 표시된것은 절대 아니며 표시된것중에 가장 위험도가 높은 정보만 나타납니다.

FDA : C등급

*	상기 임부투여에 대한 정보는 전산처리 되면서 입력 오류 가능성이 존재합니다. 오류 가능성을 최소화하기 위하여 많은 노력을 기울이고 있으나, 그 정확성에 대하여 확신을 드릴 수 없습니다. 이에 대해 회사는 책임을 지지 않습니다.
*	반드시 공신력 있는 문헌을 다시 한번 참고 하시기 바라며 의사 또는 약사의 판단에 따라 투여여부가 결정되어야 합니다.

Pharmacokinetics

유료정보입니다.

병용금기 및 연령대금기 근거조회

[병용금기 및 연령대금기 근거조회]

제형별 복약지도

[점안액]

보관상 주의

조제시 주의

심사정보

항목	내용
DUR 관련 고시	[병용연령금기 의약품 / 임부금기 의약품 / 비용효과적 함량 의약품 / 안전성 관련 급여중지 의약품]

학술정보

항목	내용
DUR (의약품사용평가)	병용금기 : 고시된 병용금기 내용은 없습니다. [상호작용/병용금기검색] 연령대금기 : 고시된 연령금기 내용은 없습니다. [연령대금기상세검색]
독성정보	Acetamide에 대한 독성정보 : 정보보기 출처: 국립독성과학원 독성물질정보DB : http://www.nitr.go.kr/nitr/contents/m134200/view.do
Mechanism of Action	Phenylephrine에 대한 Mechanism_Of_Action 정보 Phenylephrine produces its ophthalmic and systemic actions by acting on alpha 1 adrenergic receptors in the pupillary dilator muscle and the vascular smooth musle, resulting in contraction of the dilator muscle and contraction of the smooth muscle in the arterioles of the conjunctiva and peripheral vasoconstriction. Phenylephrine decreases nasal congestion by acting on alpha 1 adrenergic receptors in the arterioles of the nasal mucosa to produce constriction. Prednisolone에 대한 Mechanism_Of_Action 정보 Glucocorticoids such as Prednisolone can inhibit leukocyte infiltration at the site of inflammation, interfere with mediators of inflammatory response, and suppress humoral immune responses. The antiinflammatory actions of glucocorticoids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. Prednisolone reduces inflammatory reaction by limiting the capillary dilatation and permeability of the vascular structures. These compounds restrict the accumulation of polymorphonuclear leukocytes and macrophages and reduce the release of vasoactive kinins. Recent research suggests that corticosteroids may inhibit the release of arachidonic acid from phospholipids, thereby reducing the formation of prostaglandins. Prednisolone is a glucocorticoid receptor agonist. On binding, the corticoreceptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing an increase or decrease in expression of specific target genes, including suppression of IL2 (interleukin 2) expression. Sulfacetamide에 대한 Mechanism_Of_Action 정보 Sulfacetamide is a competitive inhibitor of bacterial para-aminobenzoic acid (PABA), an essential component for bacterial growth (according to the Woods-Fildes theory). The inhibited reaction is necessary in these organisms for the synthesis of folic acid.
Pharmacology	Phenylephrine에 대한 Pharmacology 정보 Phenylephrine is a powerful vasoconstrictor. It is used as a mydriatic, nasal decongestant, and cardiotonic agent. Phenylephrine is a postsynaptic alpha-receptor stimulant with little effect on the beta receptors of the heart. Parenteral administration of Phenylephrine causes a rise in systolic and diastolic pressures, cardiac output is slightly decreased and peripheral resistance is considerably increased, most vascular beds are constricted; renal, splanchnic, cutaneous, and limb blood flows are reduced but coronary blood flow is increased. Pulmonary vessels are constricted, and pulmonary arterial pressure is raised. This alpha receptor sympathetic agonist is also used locally because its vasoconstrictor and mydriatic action. Prednisolone에 대한 Pharmacology 정보 Prednisolone is a synthetic glucocorticoid used as antiinflammatory or immunosuppressive agent. Prednisolone is indicated in the treatment of various conditions, including congenital adrenal hyperplasia, psoriatic arthritis, systemic lupus erythematosus, bullous dermatitis herpetiformis, seasonal or perennial allergic rhinitis, allergic corneal marginal ulcers, symptomatic sarcoidosis, idiopathic thrombocytopenic purpura in adults, leukemias and lymphomas in adults, and ulcerative colitis. Glucocorticoids are adrenocortical steroids and cause profound and varied metabolic effects. In addition, they modify the body's immune responses to diverse stimuli. Sulfacetamide에 대한 Pharmacology 정보 Sulfacetamide is a sulfonamide antibiotic. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections. Their antibacterial action is inhibited by pus.
Metabolism	Phenylephrine에 대한 Metabolism 정보 # Phase_1_Metabolizing_Enzyme:Monoamine oxidase type A (MAO-A) Prednisolone에 대한 Metabolism 정보 # Phase_1_Metabolizing_Enzyme:Cytochrome P450 3A4 (CYP3A4)
Protein Binding	Phenylephrine에 대한 단백결합 정보 95% binding-plasma proteins Prednisolone에 대한 단백결합 정보 Very high (>90%) Sulfacetamide에 대한 단백결합 정보 Not Available
Half-life	Phenylephrine에 대한 반감기 정보 2.1 to 3.4 hours Prednisolone에 대한 반감기 정보 2-3 hours Sulfacetamide에 대한 반감기 정보 7-12.8 hours
Absorption	Phenylephrine에 대한 Absorption 정보 Reduced bioavailability (compared to pseudoephedrine) following oral administration due to significant first-pass metabolism. Prednisolone에 대한 Absorption 정보 Readily absorbed by gastrointestinal tract, peak plasma concentration is reached 1-2 hours after administration.
Pharmacokinetics	Phenylephrine HCl의 약물동력학자료 효과발현시간 근육주사, 피하주사 : 10~15분 이내 정맥주사 : 즉시 효과지속시간 근육주사 : 30분 ~ 2시간 정맥주사 : 15~30분 피하주사 : 1시간 대사 : Phenolic 포합체로 대사됨. Monoamine oxidase에 의해 간과 장에서 대사됨. 반감기 : 2.5 시간 소실 : 신배설 (90%) Prednisolone acetate의 약물동력학자료 단백결합 : 65∼91% (용량 의존적) 대사 : 일차적으로 간에서 대사되나 대부분의 조직에서도 대사가 일어나며 비활성형 대사체가 생성된다. 반감기 : 3.6시간 생리적 반감기 : 18-36시간 말기 신질환 환자에서의 반감기 : 3∼5시간 소실 : 대부분 glucuronides, sulfates 포합체나 비포합 대사체로 신배설 된다. Sulfacetamide sodium의 약물동력학자료 반감기 : 7-13 시간 소실 : 미변화체로 신배설
Biotransformation	Phenylephrine에 대한 Biotransformation 정보 Oral phenylephrine is extensively metabolised by monoamine oxidase, an enzyme which is present in the stomach and liver. Prednisolone에 대한 Biotransformation 정보 Excreted in the urine as either free or glucoconjugate. Sulfacetamide에 대한 Biotransformation 정보 Not Available
Toxicity	Phenylephrine에 대한 Toxicity 정보 Not Available Prednisolone에 대한 Toxicity 정보 LD₅₀=500 mg/kg (oral, rat), short-term side effects include high blood glucose levels and fluid retention. Long term side effects include Cushing's syndrome, weight gain, osteoporosis, glaucoma, type II diabetes and adrenal suppression. Sulfacetamide에 대한 Toxicity 정보 Oral LD₅₀ Mouse : 16500 mg/kg. Side effects include moderate to severe erythema (redness) and moderate edema (raised kin), nausea, vomiting, headache, dizziness, and tiredness. Higher exposure causes unconsciousness.
Drug Interactions	Phenylephrine에 대한 Drug_Interactions 정보 Alseroxylon Increased arterial pressureIsocarboxazid Increased arterial pressureDeserpidine Increased arterial pressureGuanethidine The agent decreases the effect of guanethidineRasagiline Increased arterial pressureMethyldopa Increased arterial pressureMidodrine Increased arterial pressurePargyline Increased arterial pressurePhenelzine Increased arterial pressureReserpine Increased arterial pressureTranylcypromine Increased arterial pressureOxytocin Possible marked increase of arterial pressureMethylergonovine Possible marked increase of arterial pressureLinezolid Possible increase of arterial pressureErgonovine Possible marked increase of arterial pressureTrimipramine The tricyclic increases the sympathomimetic effectProtriptyline The tricyclic increases the sympathomimetic effectNortriptyline The tricyclic increases the sympathomimetic effectClomipramine The tricyclic increases the sympathomimetic effectAmitriptyline The tricyclic increases the sympathomimetic effectAmoxapine The tricyclic increases the sympathomimetic effectDesipramine The tricyclic increases the sympathomimetic effectDoxepin The tricyclic increases the sympathomimetic effectImipramine The tricyclic increases the sympathomimetic effectMoclobemide Moclobemide increases the sympathomimetic effect Prednisolone에 대한 Drug_Interactions 정보 Ambenonium The corticosteroid decreases the effect of anticholinesterasesEdrophonium The corticosteroid decreases the effect of anticholinesterasesNeostigmine The corticosteroid decreases the effect of anticholinesterasesPyridostigmine The corticosteroid decreases the effect of anticholinesterasesWarfarin The corticosteroid alters the anticoagulant effectAcenocoumarol The corticosteroid alters the anticoagulant effectDicumarol The corticosteroid alters the anticoagulant effectAnisindione The corticosteroid alters the anticoagulant effectMidodrine Increased arterial pressureAspirin The corticosteroid decreases the effect of salicylatesBismuth Subsalicylate The corticosteroid decreases the effect of salicylatesSalicylate-magnesium The corticosteroid decreases the effect of salicylatesSalicylate-sodium The corticosteroid decreases the effect of salicylatesSalsalate The corticosteroid decreases the effect of salicylatesTrisalicylate-choline The corticosteroid decreases the effect of salicylatesTalbutal The barbiturate decreases the effect of the corticosteroidSecobarbital The barbiturate decreases the effect of the corticosteroidQuinidine barbiturate The barbiturate decreases the effect of the corticosteroidPrimidone The barbiturate decreases the effect of the corticosteroidPhenobarbital The barbiturate decreases the effect of the corticosteroidPentobarbital The barbiturate decreases the effect of the corticosteroidMethylphenobarbital The barbiturate decreases the effect of the corticosteroidMethohexital The barbiturate decreases the effect of the corticosteroidHexobarbital The barbiturate decreases the effect of the corticosteroidHeptabarbital The barbiturate decreases the effect of the corticosteroidDihydroquinidine barbiturate The barbiturate decreases the effect of the corticosteroidButethal The barbiturate decreases the effect of the corticosteroidButalbital The barbiturate decreases the effect of the corticosteroidButabarbital The barbiturate decreases the effect of the corticosteroidAprobarbital The barbiturate decreases the effect of the corticosteroidAmobarbital The barbiturate decreases the effect of the corticosteroidChlorotrianisene The estrogenic agent increases the effect of the corticosteroidClomifene The estrogenic agent increases the effect of the corticosteroidDiethylstilbestrol The estrogenic agent increases the effect of the corticosteroidEstradiol The estrogenic agent increases the effect of the corticosteroidEstriol The estrogenic agent increases the effect of the corticosteroidConjugated Estrogens The estrogenic agent increases the effect of the corticosteroidEstrone The estrogenic agent increases the effect of the corticosteroidEstropipate The estrogenic agent increases the effect of the corticosteroidEthinyl Estradiol The estrogenic agent increases the effect of the corticosteroidMestranol The estrogenic agent increases the effect of the corticosteroidQuinestrol The estrogenic agent increases the effect of the corticosteroidEthotoin The enzyme inducer decreases the effect of the corticosteroidFosphenytoin The enzyme inducer decreases the effect of the corticosteroidMephenytoin The enzyme inducer decreases the effect of the corticosteroidPhenytoin The enzyme inducer decreases the effect of the corticosteroidRifampin The enzyme inducer decreases the effect of the corticosteroidItraconazole The imidazole increases the effect and toxicity of the corticosteroidKetoconazole The imidazole increases the effect and toxicity of the corticosteroid Sulfacetamide에 대한 Drug_Interactions 정보 Not Available
CYP450 Drug Interaction	[CYP450 Table직접조회]
Food Interaction	Phenylephrine에 대한 Food Interaction 정보 Take without regard to meals. Prednisolone에 대한 Food Interaction 정보 Take with food to reduce gastric irritation.Avoid alcohol. Avoid caffeine.
Drug Target	[Drug Target]
Description	Phenylephrine에 대한 Description 정보 An alpha-adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent. [PubChem] Prednisolone에 대한 Description 정보 A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. [PubChem] Sulfacetamide에 대한 Description 정보 An anti-infective agent that is used topically to treat skin infections and orally for urinary tract infections. [PubChem]
Dosage Form	Phenylephrine에 대한 Dosage_Form 정보 Liquid IntramuscularLiquid IntravenousLiquid OphthalmicOintment TopicalSolution IntravenousSolution / drops OphthalmicStrip OralTablet Oral Prednisolone에 대한 Dosage_Form 정보 Liquid OralSolution OralSolution / drops OphthalmicSuspension OphthalmicTablet Oral Sulfacetamide에 대한 Dosage_Form 정보 Liquid OphthalmicOintment OphthalmicSolution / drops Ophthalmic
Drug Category	Phenylephrine에 대한 Drug_Category 정보 Adrenergic alpha-AgonistsCardiotonic AgentsMydriaticsNasal DecongestantsSympathomimeticsVasoconstrictor Agents Prednisolone에 대한 Drug_Category 정보 Adrenergic AgentsAnti-inflammatory AgentsAntineoplastic AgentsAntineoplastic Agents, HormonalGlucocorticoids Sulfacetamide에 대한 Drug_Category 정보 Anti-Bacterial AgentsAnti-Infective Agents, LocalAnti-Infective Agents, Urinary
Smiles String Canonical	Phenylephrine에 대한 Smiles_String_canonical 정보 CNCC(O)C1=CC(O)=CC=C1 Prednisolone에 대한 Smiles_String_canonical 정보 CC12CC(O)C3C(CCC4=CC(=O)C=CC34C)C1CCC2(O)C(=O)CO Sulfacetamide에 대한 Smiles_String_canonical 정보 CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1
Smiles String Isomeric	Phenylephrine에 대한 Smiles_String_isomeric 정보 CNC[C@H](O)C1=CC(O)=CC=C1 Prednisolone에 대한 Smiles_String_isomeric 정보 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO Sulfacetamide에 대한 Smiles_String_isomeric 정보 CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1
InChI Identifier	Phenylephrine에 대한 InChI_Identifier 정보 InChI=1/C9H13NO2/c1-10-6-9(12)7-3-2-4-8(11)5-7/h2-5,9-12H,6H2,1H3/t9-/m0/s1 Prednisolone에 대한 InChI_Identifier 정보 InChI=1/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1 Sulfacetamide에 대한 InChI_Identifier 정보 InChI=1/C8H10N2O3S/c1-6(11)10-14(12,13)8-4-2-7(9)3-5-8/h2-5H,9H2,1H3,(H,10,11)/f/h10H
Chemical IUPAC Name	Phenylephrine에 대한 Chemical_IUPAC_Name 정보 3-[(1R)-1-hydroxy-2-methylaminoethyl]phenol Prednisolone에 대한 Chemical_IUPAC_Name 정보 (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one Sulfacetamide에 대한 Chemical_IUPAC_Name 정보 N-(4-aminophenyl)sulfonylacetamide
Drug-Induced Toxicity Related Proteins	PREDNISOLONE 의 Drug-Induced Toxicity Related Protein정보 Replated Protein:DNA topoisomerase 1 Drug:prednisolone Toxicity:appearance of apoptotic cells. [바로가기]

사용자컨텐츠

항목

내용

핵심 요약 정보